Conducting collaborative research that brings together the laboratory and clinic to develop new treatments for patients.
Telethon Kids Cancer Centre is headed by leading brain cancer researcher Professor Terry Johns, Professor in Children’s Cancer Research.
The research of TKCC includes laboratory-based scientists, paediatric oncologists, epidemiologists, support staff, and include many higher degree (mainly PhD) and Honours students. Our research is organised into collaborative programs of laboratory-based research and translational research.
Our goal is to discover new therapies - therapies that are more effective and less toxic - to fight the most aggressive cancers in babies and children. Our research focuses on:
- Testing existing drugs and new compounds to improve patient outcomes.
- Understanding the biology of individual cancers to identify weaknesses to target.
- Determining why apparently similar cancer cells from individual patients respond differently to treatment.
- Harnessing the power of the body's own immune system to fight cancer cells.
- Developing new treatments with industry partners to feed our drug development pipeline.
Our core facilities and platform technologies provide the backbone of TKCC and ensure that our cancer researchers have cutting-edge tools and know-how to expedite their discoveries. The institute's Scientific Services and Laboratory Managers, whose important role is also to identify, import, and develop new technologies, support these platforms.
For information on potential collaborative or contract research agreements, or material transfer agreements with the laboratories of TKCC, contact Research Development.